Tiffany Yu-Tin Chen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calciphylaxis | 2 | 2018 | 122 | 0.680 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2017 | 252 | 0.620 |
Why?
|
| Angiodysplasia | 1 | 2017 | 23 | 0.610 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2017 | 26 | 0.590 |
Why?
|
| Neuromuscular Agents | 1 | 2018 | 134 | 0.560 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2017 | 65 | 0.560 |
Why?
|
| Migraine with Aura | 1 | 2018 | 203 | 0.540 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2018 | 212 | 0.510 |
Why?
|
| Lacrimal Apparatus | 1 | 2017 | 224 | 0.500 |
Why?
|
| Eye Neoplasms | 1 | 2017 | 313 | 0.500 |
Why?
|
| Blood Vessels | 1 | 2017 | 1124 | 0.400 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 2028 | 0.370 |
Why?
|
| Laryngoplasty | 2 | 2017 | 53 | 0.280 |
Why?
|
| Skin | 1 | 2017 | 4353 | 0.240 |
Why?
|
| Thrombosis | 1 | 2017 | 2966 | 0.230 |
Why?
|
| Bicycling | 1 | 2023 | 176 | 0.200 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2021 | 104 | 0.180 |
Why?
|
| Privacy | 1 | 2021 | 237 | 0.170 |
Why?
|
| Synthetic Biology | 1 | 2021 | 179 | 0.170 |
Why?
|
| Thyroid Neoplasms | 2 | 2020 | 2274 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 11363 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 719 | 0.140 |
Why?
|
| Walking | 1 | 2023 | 1177 | 0.130 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2017 | 234 | 0.130 |
Why?
|
| Biopsy | 2 | 2017 | 6756 | 0.130 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2016 | 139 | 0.130 |
Why?
|
| Mouth Neoplasms | 1 | 2020 | 601 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2017 | 2638 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2020 | 4029 | 0.110 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 267 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 495 | 0.100 |
Why?
|
| Papillomaviridae | 1 | 2017 | 1118 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2017 | 1179 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2021 | 3328 | 0.100 |
Why?
|
| Warfarin | 1 | 2018 | 1493 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2021 | 3123 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2211 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2187 | 0.080 |
Why?
|
| Collagen | 1 | 2016 | 2684 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2021 | 6191 | 0.080 |
Why?
|
| Kidney Neoplasms | 2 | 2021 | 4229 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2017 | 1877 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2020 | 77098 | 0.070 |
Why?
|
| Middle Aged | 7 | 2020 | 213127 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 1585 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 57683 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12958 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 2536 | 0.060 |
Why?
|
| Injections | 2 | 2017 | 840 | 0.060 |
Why?
|
| Male | 8 | 2021 | 349538 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2712 | 0.060 |
Why?
|
| Female | 9 | 2021 | 379592 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2021 | 40450 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5304 | 0.060 |
Why?
|
| Adult | 6 | 2020 | 213712 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2018 | 4595 | 0.050 |
Why?
|
| Aged | 6 | 2020 | 162944 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5171 | 0.050 |
Why?
|
| Histological Techniques | 1 | 2021 | 198 | 0.050 |
Why?
|
| Transportation | 1 | 2023 | 211 | 0.050 |
Why?
|
| Information Theory | 1 | 2021 | 51 | 0.050 |
Why?
|
| Humans | 13 | 2023 | 742088 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 13853 | 0.050 |
Why?
|
| Geographic Information Systems | 1 | 2023 | 281 | 0.050 |
Why?
|
| Rabbits | 2 | 2017 | 4886 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15530 | 0.050 |
Why?
|
| Histocytochemistry | 1 | 2021 | 718 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 85649 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 841 | 0.040 |
Why?
|
| Mitotic Index | 1 | 2017 | 172 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 1653 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13019 | 0.040 |
Why?
|
| Workflow | 1 | 2021 | 846 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 29717 | 0.030 |
Why?
|
| Microscopy | 1 | 2021 | 903 | 0.030 |
Why?
|
| Thrombophilia | 1 | 2018 | 305 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2020 | 11001 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 56350 | 0.030 |
Why?
|
| Necrosis | 1 | 2017 | 1643 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2906 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3612 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2017 | 706 | 0.030 |
Why?
|
| Risk Factors | 1 | 2017 | 72145 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4839 | 0.020 |
Why?
|
| Reference Values | 1 | 2018 | 4982 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2017 | 2899 | 0.020 |
Why?
|
| Child | 1 | 2017 | 77478 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29010 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18006 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3507 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14720 | 0.020 |
Why?
|
| Sex Factors | 1 | 2018 | 10392 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19862 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9185 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10472 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18355 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11470 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16331 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23320 | 0.010 |
Why?
|
| United States | 1 | 2023 | 69693 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 168561 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40054 | 0.010 |
Why?
|